Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems

First moderate complexity molecular test for sexually transmitted infections on fully automated, high throughput platform Broad set of urogenital sample claims ensure greatest flexibility for patient access New test for most common sexually transmitt... Diagnostics, FDA Roche Group, cobas, cobas CT/NG, chlamydia, gonorrhoeae
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news